PAS
NMRA icon

Point72 Asia (Singapore)’s Neumora Therapeutics NMRA Stock Holding History

Point72 Asia (Singapore)’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$57.2K Buy
+31,444
New +$50.8K 0.01% 548

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Asia (Singapore)'s NMRA Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Neumora Therapeutics (NMRA) in Q3 2025: 31,444 shares worth $57.2K. The stake represents 0.01% of the portfolio and ranks #548 among its holdings.

93 funds tracked by Wall St. Rank hold NMRA as of Q3 2025.

  • Point72 Asia (Singapore) held 31,444 shares of Neumora Therapeutics worth $57.2K as of Q3 2025.
  • Neumora Therapeutics was a new Point72 Asia (Singapore) position in Q3 2025.
  • Neumora Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #548 holding.
  • 93 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.